Nathaniel Marchetti, DO, Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Medical Director of the Respiratory Intensive Care Unit at Temple University Hospital, participated in a Q&A with Consultant360 about the role of eosinophils as a biomarker to inform treatment decisions for patients with chronic obstructive pulmonary disease (COPD).